Cyclophosphamide/Dexamethasone/Rituximab Regimen
**Semantic type:** Therapeutic or Preventive Procedure
**Definition:** A regimen consisting of cyclophosphamide, dexamethasone and rituximab that may be used in the treatment of Waldenstrom macroglobulinemia.
**Synonyms:** - Cyclophosphamide-Dexamethasone-Rituximab - Cyclophosphamide/Dexamethasone/Rituximab - Cytoxan/Decadron/Rituxan - DRC - DRC - DRC (SC rituximab) (rituximab-abbs) - DRC (SC rituximab) (rituximab-arrx) - DRC (SC rituximab) (rituximab-blit) - DRC (SC rituximab) (rituximab-pvvr) - DRC (SC rituximab) (rituximab-rite) - DRC (SC rituximab) (rituximab-rixa) - DRC (SC rituximab) (rituximab-rixi) - DRC (rituximab-abbs) - DRC (rituximab-arrx) - DRC (rituximab-blit) - DRC (rituximab-pvvr) - DRC (rituximab-rite) - DRC (rituximab-rixa) - DRC (rituximab-rixi) - DRC Regimen - Dexamethasone/Rituximab/Cyclophosphamide - Dexamethasone/Rituximab/Cyclophosphamide Regimen - Oral Cyclophosphamide/Dexamethasone Plus Rituximab - Oral Cyclophosphamide/Dexamethasone/Rituximab
/api/v1/systems/nci_thesaurus/nodes/C160556Hierarchy Explorer
Cross-system equivalences0
No cross-system equivalences mapped for this node.